{"version":"1.0","type":"link","title":"In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19/PD-L1 leukemia.","author_name":"Yang Y 외","author_url":"https://prs-insight.online/author/Yang%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/162409","thumbnail_width":1200,"thumbnail_height":630}